JPY 551.0
(-1.43%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 3.27 Billion JPY | -7.13% |
2022 | 3.34 Billion JPY | -10.96% |
2021 | 4.2 Billion JPY | 13.68% |
2020 | 3.47 Billion JPY | -12.24% |
2019 | 4.09 Billion JPY | 16.57% |
2018 | 3.45 Billion JPY | 11.96% |
2017 | 3.1 Billion JPY | 11.05% |
2016 | 2.64 Billion JPY | 8.91% |
2015 | 2.56 Billion JPY | 9.78% |
2014 | 2.33 Billion JPY | 51.29% |
2013 | 1.54 Billion JPY | 209.35% |
2012 | 494.62 Million JPY | 0.0% |
2011 | - JPY | -100.0% |
2010 | 1.14 Billion JPY | -16.48% |
2009 | -2.06 Billion JPY | -3.39% |
2008 | 1.46 Billion JPY | -26.04% |
2007 | 2.79 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 765.08 Million JPY | -18.2% |
2024 Q2 | 591.47 Million JPY | -22.69% |
2023 Q4 | 970.4 Million JPY | 3.2% |
2023 FY | - JPY | -7.13% |
2023 Q1 | 673.68 Million JPY | -18.94% |
2023 Q2 | 644.46 Million JPY | -4.34% |
2023 Q3 | 940.3 Million JPY | 45.9% |
2022 Q3 | 971.36 Million JPY | 24.34% |
2022 Q4 | 831.11 Million JPY | -14.44% |
2022 Q1 | 815.39 Million JPY | -16.43% |
2022 Q2 | 781.22 Million JPY | -4.19% |
2022 FY | - JPY | -10.96% |
2021 Q3 | 1.23 Billion JPY | 53.44% |
2021 Q4 | 975.7 Million JPY | -20.81% |
2021 Q1 | 851.4 Million JPY | -6.56% |
2021 Q2 | 802.93 Million JPY | -5.69% |
2021 FY | - JPY | 13.68% |
2020 Q2 | 875.71 Million JPY | 59.97% |
2020 Q4 | 911.16 Million JPY | -12.83% |
2020 FY | - JPY | -12.24% |
2020 Q1 | 547.43 Million JPY | -41.65% |
2020 Q3 | 1.04 Billion JPY | 19.36% |
2019 Q3 | 1.1 Billion JPY | 19.9% |
2019 Q4 | 938.2 Million JPY | -14.96% |
2019 FY | - JPY | 16.57% |
2019 Q1 | 945.6 Million JPY | 3.8% |
2019 Q2 | 920.16 Million JPY | -2.69% |
2018 Q2 | 672.01 Million JPY | -5.4% |
2018 FY | - JPY | 11.96% |
2018 Q4 | 910.95 Million JPY | -14.92% |
2018 Q3 | 1.07 Billion JPY | 59.33% |
2018 Q1 | 710.38 Million JPY | -6.68% |
2017 Q1 | 699.69 Million JPY | 7.63% |
2017 Q3 | 946.85 Million JPY | 62.43% |
2017 Q4 | 761.23 Million JPY | -19.6% |
2017 Q2 | 582.93 Million JPY | -16.69% |
2017 FY | - JPY | 11.05% |
2016 Q4 | 650.08 Million JPY | -20.54% |
2016 Q2 | 654.68 Million JPY | 16.69% |
2016 Q1 | 561.05 Million JPY | -18.61% |
2016 Q3 | 818.14 Million JPY | 24.97% |
2016 FY | - JPY | 8.91% |
2015 Q4 | 689.31 Million JPY | -4.41% |
2015 FY | - JPY | 9.78% |
2015 Q2 | 543.39 Million JPY | 8.22% |
2015 Q1 | 502.1 Million JPY | -1.79% |
2015 Q3 | 721.1 Million JPY | 32.7% |
2014 Q3 | 769.96 Million JPY | 57.08% |
2014 Q1 | 476.19 Million JPY | -18.18% |
2014 FY | - JPY | 51.29% |
2014 Q4 | 511.23 Million JPY | -33.6% |
2014 Q2 | 490.17 Million JPY | 2.94% |
2013 Q2 | 262.59 Million JPY | 75.7% |
2013 FY | - JPY | 209.35% |
2013 Q4 | 581.99 Million JPY | 23.99% |
2013 Q3 | 469.37 Million JPY | 78.74% |
2013 Q1 | 149.45 Million JPY | -44.46% |
2012 Q1 | 418.69 Million JPY | 0.0% |
2012 Q2 | 289.76 Million JPY | -30.79% |
2012 Q3 | -533.56 Million JPY | -284.14% |
2012 Q4 | 269.09 Million JPY | 150.43% |
2012 FY | - JPY | 0.0% |
2011 Q3 | 686.35 Million JPY | 44.62% |
2011 Q2 | 474.59 Million JPY | -32.28% |
2011 Q1 | 700.84 Million JPY | 1.56% |
2011 FY | - JPY | -100.0% |
2010 FY | - JPY | -16.48% |
2010 Q3 | 718.58 Million JPY | 52.83% |
2010 Q4 | 690.08 Million JPY | -3.97% |
2010 Q2 | 470.18 Million JPY | -35.28% |
2010 Q1 | 726.47 Million JPY | -26.97% |
2009 Q2 | 588.14 Million JPY | -11.7% |
2009 Q1 | 666.04 Million JPY | -27.65% |
2009 Q4 | 994.74 Million JPY | 27.63% |
2009 FY | - JPY | -3.39% |
2009 Q3 | 779.38 Million JPY | 32.51% |
2008 FY | - JPY | -26.04% |
2008 Q3 | 866.64 Million JPY | 0.0% |
2008 Q4 | 920.61 Million JPY | 6.23% |
2007 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
DVx Inc. | 807.98 Million JPY | -305.121% |
Seikagaku Corporation | 2.09 Billion JPY | -56.169% |
Eiken Chemical Co., Ltd. | 5.7 Billion JPY | 42.624% |
Create Medic Co., Ltd. | 1.39 Billion JPY | -135.254% |
PHC Holdings Corporation | 39.08 Billion JPY | 91.626% |
Techno Medica Co., Ltd. | 1.95 Billion JPY | -67.586% |
Rion Co., Ltd. | 4.37 Billion JPY | 25.21% |
Nihon Kohden Corporation | 23.44 Billion JPY | 86.038% |
Fukuda Denshi Co., Ltd. | 36.23 Billion JPY | 90.966% |
Japan Lifeline Co., Ltd. | 12.39 Billion JPY | 73.581% |
3-D Matrix, Ltd. | 2.09 Billion JPY | -56.468% |
CYBERDYNE Inc. | -2 Million JPY | 163765.55% |